Research Articles

• Open Access

  Role of Chitinase 3–like 1 as a Biomarker in Multiple SclerosisA Systematic Review and Meta-analysis

  Stefano Floro, Tiziana Carandini, Anna Margherita Pietroboni, Milena Alessandra De Riz, Elio Scarpini, Daniela Galimberti

  • Abstract
  • Full Text
  • Full Text (PDF)
• Open Access

  Transcription Factor c-Maf Promotes Immunoregulation of Programmed Cell Death 1–Expressed CD8⁺ T Cells in Multiple Sclerosis

  Shusuke Koto, Norio Chihara, Ritsu Akatani, Hiroko Nakano, Atsushi Hara, Kenji Sekiguchi, Riki Matsumoto, Tatsushi Toda

  • Abstract
  • Full Text
  • Full Text (PDF)
• Open Access

  Pure Relapsing Short MyelitisPart of the Multiple Sclerosis Spectrum or New Entity?

  Zélia Poullet, Julie Pique, Adil Maarouf, Clemence Boutiere, Audrey Rico, Sarah Demortiere, Pierre Durozard, Caroline Papeix, Elisabeth Maillart, Nicolas Collongues, Xavier Ayrignac, Helene Zephir, Romain Deschamps, Jonathan Ciron, Jean Pelletier, Romain Marignier, Bertrand Audoin

  • Abstract
  • Full Text
  • Full Text (PDF)
• Open Access

  CNS Antigen-Specific Neuroinflammation Attenuates Ischemic Stroke With Involvement of Polarized Myeloid Cells

  Kirsten Guse, Nina Hagemann, Lisa Thiele, Jana Remlinger, Anke Salmen, Robert Hoepner, Irene Keller, Patricia Meyer, Denis Grandgirard, Stephen L. Leib, Erik Vassella, Giuseppe Locatelli, Dirk M. Hermann, Andrew Chan

  • Abstract
  • Full Text
  • Full Text (PDF)
• Open Access

  Heterogeneity of Acetylcholine Receptor Autoantibody–Mediated Complement Activity in Patients With Myasthenia Gravis

  Abeer H. Obaid, Chryssa Zografou, Douangsone D. Vadysirisack, Bailey Munro-Sheldon, Miriam L. Fichtner, Bhaskar Roy, William M. Philbrick, Jeffrey L. Bennett, Richard J. Nowak, Kevin C. O'Connor

  • Abstract
  • Full Text
  • Full Text (PDF)
• Open Access

  Neurosarcoidosis of the Cauda EquinaClinical Course, Radiographic and Electrodiagnostic Findings, Response to Treatment, and Outcomes

  Gabriela Alejandra Bou, Rocio Garcia-Santibanez, Alexander Jordan Castilho, Spencer Kristian Hutto

  • Abstract
  • Full Text
  • Full Text (PDF)
• Open Access

  Retinal Hyperreflecting Foci Associate With Cortical Pathology in Multiple Sclerosis

  Marta Pengo, Silvia Miante, Silvia Franciotta, Marta Ponzano, Tommaso Torresin, Francesca Bovis, Francesca Rinaldi, Paola Perini, Martina Saiani, Monica Margoni, Alessandra Bertoldo, Maria Pia Sormani, Elisabetta Pilotto, Edoardo Midena, Paolo Gallo, Marco Puthenparampil

  • Abstract
  • Full Text
  • Full Text (PDF)
• Open Access

  Innate Immune Cell–Related Pathology in the Thalamus Signals a Risk for Disability Progression in Multiple Sclerosis

  Olavi Misin, Markus Matilainen, Marjo Nylund, Eveliina Honkonen, Eero Rissanen, Marcus Sucksdorff, Laura Airas

  • Abstract
  • Full Text
  • Full Text (PDF)
• Open Access

  Transitioning From S1P Receptor Modulators to B Cell–Depleting Therapies in Multiple SclerosisClinical, Radiographic, and Laboratory Data

  William M. Rowles, Wan-Yu Hsu, Kira McPolin, Alyssa Li, Steven Merrill, Chu-Yueh Guo, Ari J. Green, Jeffrey Marc Gelfand, Riley M. Bove

  • Abstract
  • Full Text
  • Full Text (PDF)
• Open Access

  Clinicopathologic Profiles of Sporadic Late-Onset Nemaline MyopathyPractical Importance of Anti–α-Actinin Immunostaining

  Bing Zhao, Tingjun Dai, Dandan Zhao, Xiaotian Ma, Cuiping Zhao, Ling Li, Yuan Sun, Yongqing Zhang, Yaping Yan, Jian-Qiang Lu, Fuchen Liu, Chuanzhu Yan

  • Abstract
  • Full Text
  • Full Text (PDF)
• Open Access

  Early Reduction of MRI Activity During 6 Months of Treatment With Cladribine Tablets for Highly Active Relapsing Multiple SclerosisMAGNIFY-MS

  Nicola de Stefano, Frederik Barkhof, Xavier Montalban, Anat Achiron, Tobias Derfuss, Andrew Chan, Suzanne Hodgkinson, Alexandre Prat, Letizia Leocani, Klaus Schmierer, Finn Sellebjerg, Patrick Vermersch, Heinz Wiendl, Birgit Keller, Claire Mwape, Sanjeev Roy, MAGNIFY-MS Study Group

  • Abstract
  • Full Text
  • Full Text (PDF)
• Open Access

  Immune Response and Safety of SARS-CoV-2 mRNA-1273 Vaccine in Patients With Myasthenia Gravis

  David Reyes-Leiva, Joaquín López-Contreras, Esther Moga, Francesc Pla-Juncà, Elionor Lynton-Pons, Ricardo Rojas-Garcia, Janina Turon-Sans, Luis Querol, Montse Olive, Rodrigo Álvarez-Velasco, Marta Caballero-Ávila, Álvaro Carbayo, Ana Vesperinas-Castro, Pere Domingo, Isabel Illa, Eduard Gallardo, Elena Cortés-Vicente

  • Abstract
  • Full Text
  • Full Text (PDF)
• Comment: Humoral and T-cell Immunities to SARS-CoV-2 Vaccines: Safety, Efficacy, and Challenges in Autoimmune Neurology

  Marinos C. Dalakas, Josep Dalmau

  • Full Text
  • Full Text (PDF)
• Open Access

  Ofatumumab Modulates Inflammatory T Cell Responses and Migratory Potential in Patients With Multiple Sclerosis

  Marina Rode von Essen, Rikke Holm Hansen, Camilla Højgaard, Cecilie Ammitzbøll, Heinz Wiendl, Finn Sellebjerg

  • Abstract
  • Full Text
  • Full Text (PDF)
• Open Access

  Paraneoplastic Cerebellar Degeneration With P/Q-VGCC vs Yo Autoantibodies

  Michael Winklehner, Jan Bauer, Verena Endmayr, Carmen Schwaiger, Gerda Ricken, Masakatsu Motomura, Shunsuke Yoshimura, Hiroshi Shintaku, Kinya Ishikawa, Yukio Tsuura, Takahiro Iizuka, Takanori Yokota, Takashi Irioka, Romana Höftberger

  • Abstract
  • Full Text
  • Full Text (PDF)